According to Chinese media the Paper, a former Chinese female executive at GlaxoSmithKline China's government affairs department who was born in 1964, should have been involved in reporting the company's bribery to the senior executives of the company and the Chinese government, as said by some employees of other foreign pharmaceutical companies in China interviewed by the Paper.